{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:16:06Z","timestamp":1778156166536,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clbc.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:56:53Z","timestamp":1773161813000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Primary Tumor Surgery in Oligometastatic Breast Cancer: A Meta-Analysis of Randomized and Observational Studies"],"prefix":"10.1016","volume":"26","author":[{"given":"Ziteng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8020-5683","authenticated-orcid":false,"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clbc.2026.03.003_bib0001","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","article-title":"5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)","volume":"31","author":"Cardoso","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.003_bib0002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-016-3974-x","article-title":"Ten-year survival in women with primary stage IV breast cancer","volume":"160","author":"Eng","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.003_bib0003","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/cam4.3618","article-title":"Trifluridine\/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): a multicenter phase II trial","volume":"10","author":"Oki","year":"2021","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.clbc.2026.03.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.70017","article-title":"Mapping the metastatic landscape: a population-based cohort study for prognostic insights into newly diagnosed stage IV breast cancer cases","volume":"4","author":"Kong","year":"2025","journal-title":"Cancer Innov"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.003_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.003_bib0006","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/jpm11060532","article-title":"Oligometastatic breast cancer: how to manage it?","volume":"11","author":"Barberi","year":"2021","journal-title":"J Pers Med"},{"issue":"10185","key":"10.1016\/j.clbc.2026.03.003_bib0007","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2026.03.003_bib0008","doi-asserted-by":"crossref","first-page":"423","DOI":"10.12688\/f1000research.52546.3","article-title":"Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies","volume":"10","author":"Petrelli","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.clbc.2026.03.003_bib0009","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2026.03.003_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"10.1016\/j.clbc.2026.03.003_bib0011","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1245\/s10434-018-6494-6","article-title":"Randomized trial comparing resection of primary tumour with No surgery in stage IV breast cancer at presentation: protocol MF07-01","volume":"25","author":"Soran","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2026.03.003_bib0012","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1200\/JCO.21.02006","article-title":"Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108)","volume":"40","author":"Khan","year":"2022","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.clbc.2026.03.003_bib0013","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S1470-2045(15)00135-7","article-title":"Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial","volume":"16","author":"Badwe","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2026.03.003_bib0014","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1245\/s10434-021-09621-8","article-title":"The effect of primary surgery in patients with de novo stage IV breast cancer with bone metastasis only (protocol BOMET MF 14-01): a multi-center, prospective registry study","volume":"28","author":"Soran","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.03.003_bib0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12282-023-01436-7","article-title":"Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)","volume":"30","author":"Imoto","year":"2023","journal-title":"Breast Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2026.03.003_bib0016","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/curroncol32100556","article-title":"Locoregional treatment in de novo bone-only metastatic breast cancer: prospective, multi-institutional real-world data, BOMETIN, protocol MF14-1a","volume":"32","author":"Soran","year":"2025","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clbc.2026.03.003_bib0017","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S0960-9776(19)30234-6","article-title":"Oligo-metastatic breast cancer: real world scenario from a single center in India","volume":"44","author":"Sharma","year":"2019","journal-title":"The Breast"},{"key":"10.1016\/j.clbc.2026.03.003_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7839041","article-title":"Systemic therapy combined with locoregional therapy improved survival in oligometastatic breast cancer: a single-center retrospective cohort study","volume":"2022","author":"Ma","year":"2022","journal-title":"J Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.03.003_bib0019","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/cncr.24873","article-title":"Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumour matter?","volume":"116","author":"Neuman","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2026.03.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55765-9","article-title":"Survival impact of primary tumour resection in de novo metastatic breast cancer patients (GEICAM\/El Alamo Registry)","volume":"9","author":"Lopez-Tarruella","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.003_bib0021","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1245\/s10434-012-2844-y","article-title":"Primary tumour extirpation in breast cancer patients who present with stage IV disease is associated with improved survival","volume":"20","author":"Lang","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.03.003_bib0022","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/ijc.IJC_169_20","article-title":"Oligometastatic breast cancer: an institutional analysis","volume":"59","author":"Gogia","year":"2022","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.clbc.2026.03.003_bib0023","series-title":"proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11","first-page":"PS1","article-title":"Abstract PS1-58: The role of resection of the primary tumour in patients with de novo oligometastatic breast cancer (OMBC)","volume":"81","author":"Debuquoy","year":"2021"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.003_bib0024","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000503847","article-title":"Local treatment in addition to endocrine therapy in hormone receptor-positive and HER2-negative oligometastatic breast cancer patients: a retrospective multicenter analysis","volume":"15","author":"Cha","year":"2020","journal-title":"Breast Care (Basel)"},{"issue":"4","key":"10.1016\/j.clbc.2026.03.003_bib0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ans.12548","article-title":"Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone","volume":"85","author":"Rhu","year":"2015","journal-title":"ANZ J Surg"},{"issue":"9 Suppl","key":"10.1016\/j.clbc.2026.03.003_bib0026","doi-asserted-by":"crossref","first-page":"PO2-06-02","DOI":"10.1158\/1538-7445.SABCS23-PO2-06-02","article-title":"Abstract PO2-06-02: characteristics and treatment patterns of de novo oligometastatic stage IV breast cancer: a single-center retrospective cohort study","volume":"84","author":"Blansky","year":"2024","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.clbc.2026.03.003_bib0027","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"15 Suppl","key":"10.1016\/j.clbc.2026.03.003_bib0028","article-title":"Incidence and implications of oligometastatic breast cancer","volume":"30","author":"Jain","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2026.03.003_bib0029","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrclinonc.2014.96","article-title":"The oligometastatic state\u2014separating truth from wishful thinking","volume":"11","author":"Palma","year":"2014","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:44:00Z","timestamp":1778154240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1526820926000352"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.03.003","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Primary Tumor Surgery in Oligometastatic Breast Cancer: A Meta-Analysis of Randomized and Observational Studies","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}